We therefore generated a TCRm bispecific T cell engager (TCRm-BiTE) comprising Trp2/H2-Kb TCRm scFv clone 13 and 2C11 anti-CD3e scFv27 (Extended Data Fig. 3b) to recruit T cells to tumor cells (Fig. 4a). This evidence concerns the gene CD3E and neoplasm.